Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Features

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Michael O'Riordan

February 19, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Features

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Michael O'Riordan

January 11, 2021

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

Advertisement

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Minorities, Poorer Patients Missing Out on Structural Heart Care

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Funding the Future: How Industry Support for CV Trials Could Evolve

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content